Richard Alexander Moore, Jr

Title: Richard Alexander Moore, Jr.: Innovator in Pharmaceutical Formulations

Introduction

Richard Alexander Moore, Jr. is a notable inventor based in San Diego, CA. He has made significant contributions to the field of pharmaceuticals, particularly in the formulation of high dosage medications. With a total of 2 patents to his name, Moore's work is recognized for its innovative approach to drug delivery systems.

Latest Patents

Moore's latest patents include a high dosage valbenazine formulation and compositions, methods, and kits related thereto. This patent focuses on solid pharmaceutical compositions with high drug loading. The formulation includes valbenazine, or a pharmaceutically acceptable salt thereof, silicified microcrystalline cellulose, isomalt, hydroxypropyl methylcellulose, partially pregelatinized maize starch, and magnesium stearate. This innovative approach aims to enhance the efficacy and delivery of valbenazine in clinical settings.

Career Highlights

Richard Alexander Moore, Jr. is currently associated with Neurocrine Biosciences, Inc., where he continues to develop groundbreaking pharmaceutical solutions. His work is pivotal in advancing treatment options for various medical conditions, showcasing his commitment to improving patient care through innovation.

Collaborations

Moore has collaborated with esteemed colleagues such as Gregory A. McClelland and Christopher F. O'Brien. These partnerships have fostered a collaborative environment that enhances the development of new pharmaceutical technologies.

Conclusion

Richard Alexander Moore, Jr. stands out as a key figure in the pharmaceutical industry, with his innovative patents and contributions to drug formulation. His work continues to impact the field positively, paving the way for future advancements in medication delivery systems.